Philips has provided an update on a field safety notice affecting certain Philips Respironics ventilators due to a potential device alarm-related issue.
As Philips Respironics settles costly legal battles over its defective breathing machines, the Securities and Exchange ...
When Philips Respironics in 2021 recalled millions of devices for treating sleep apnea, the company warned users of potential ...
That's why plaintiffs' lawyer Garry Jones said he expected his client, who used the breathing device for two years before ...
The ventilators—the Philips Respironics, Inc. Trilogy EVO, Trilogy EV300, Trilogy Evo O2, and Trilogy Evo Universal—have been assigned a Class I recall, which is the most serious type of ...
FDA today identified Philips Respironics Trilogy Evo continuous ventilator recall as Class I, over a month after the company initiated the voluntary correction in March. The ventilators affected by ...
The company earlier this year decided to halt new sales in the US of the machines made by subsidiary Philips Respironics. The company has reached an agreement with the plaintiffs “to resolve the ...
Royal Philips said it has reached a $1.1 billion settlement in the U.S. related its Respironics ventilators, and backed its full-year guidance. The Dutch health-technology group said Monday that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results